表紙
市場調查報告書
商品編碼
1087375

白塞氏病治療藥的全球市場:2022年∼2026年

Global Behcet's Disease Therapeutics Market 2022-2026

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球白塞氏病治療藥的市場規模在2022年∼2026年間,預測將成長到2億8,172萬美元,在預測期間中預計將以年複合成長率6.68%成長。

市場成長的主要因素有大量使用非適應症、特定醫藥品指定以及對罕見疾病的研究資金增加。

本報告提供全球白塞氏病治療藥市場相關調查分析,網羅整體分析,市場規模與預測,趨勢,成長促進因素,課題,提供著約25供應商的供應商分析等。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2021年
  • 市場預測:2021年∼2026年的預測

第4章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供應商談判力
  • 新興企業的威脅
  • 替代品的威脅
  • 競爭企業的威脅
  • 市場情況

第5章 市場區隔:各產品

  • 市場區隔
  • 比較:各產品
  • 小分子 - 市場規模與預測:2021年∼2026年
  • 生技藥品 - 市場規模與預測:2021年∼2026年
  • 市場機會:各產品

第6章 客戶形勢

  • 客戶形勢概要

第7章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美 - 市場規模與預測:2021年∼2026年
  • 歐洲 - 市場規模與預測:2021年∼2026年
  • 亞洲 - 市場規模與預測:2021年∼2026年
  • 其他地區(ROW) - 市場規模與預測:2021年∼2026年
  • 美國 - 市場規模與預測:2021年∼2026年
  • 加拿大 - 市場規模與預測:2021年∼2026年
  • 英國 - 市場規模與預測:2021年∼2026年
  • 德國 - 市場規模與預測:2021年∼2026年
  • 日本 - 市場規模與預測:2021年∼2026年
  • 法國 - 市場規模與預測:2021年∼2026年
  • 市場機會:各地區形勢

第8章 促進因素,課題,及趨勢

  • 推動市場要素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第9章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson
  • Mitsubishi Chemical Holdings Corp.
  • Novartis AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Viatris Inc.

第11章 附錄

目錄
Product Code: IRTNTR73638

Technavio has been monitoring the Behcet's disease therapeutics market and it is poised to grow by $ 281.72 mn during 2022-2026, decelerating at a CAGR of 6.68% during the forecast period. Our report on the Behcet's disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by heavy use of off-label drugs, special drug designations, and increasing research funding for rare diseases.

Behcet's disease therapeutics market analysis includes product segment and geographic landscape.

Technavio's Behcet's disease therapeutics market is segmented as below:

By Product

  • Small molecules
  • Biologics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing awareness of rare diseases as one of the prime reasons driving the Behcet's disease therapeutics market growth during the next few years. Also, strategic alliances and the advent of novel therapeutics will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on Behcet's disease therapeutics market covers the following areas:

  • Behcet's disease therapeutics market sizing
  • Behcet's disease therapeutics market forecast
  • Behcet's disease therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Behcet's disease therapeutics market vendors that include AbbVie Inc., Amgen Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson, Mitsubishi Chemical Holdings Corp., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Viatris Inc. Also, Behcet's disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
  • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product
  • Exhibit 26: Chart on Comparison by Product
  • Exhibit 27: Data Table on Comparison by Product
  • 5.3 Small molecules - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
  • 5.4 Biologics - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Product
  • Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Canada - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 Germany - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.11 Japan - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.12 France - Market size and forecast 2021-2026
  • Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 7.13 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 AbbVie Inc.
  • Exhibit 89: AbbVie Inc. - Overview
  • Exhibit 90: AbbVie Inc. - Product / Service
  • Exhibit 91: AbbVie Inc. - Key offerings
  • 10.4 Amgen Inc.
  • Exhibit 92: Amgen Inc. - Overview
  • Exhibit 93: Amgen Inc. - Product / Service
  • Exhibit 94: Amgen Inc. - Key offerings
  • 10.5 F. Hoffmann La Roche Ltd.
  • Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.6 Johnson and Johnson
  • Exhibit 100: Johnson and Johnson - Overview
  • Exhibit 101: Johnson and Johnson - Business segments
  • Exhibit 102: Johnson and Johnson - Key news
  • Exhibit 103: Johnson and Johnson - Key offerings
  • Exhibit 104: Johnson and Johnson - Segment focus
  • 10.7 Mitsubishi Chemical Holdings Corp.
  • Exhibit 105: Mitsubishi Chemical Holdings Corp. - Overview
  • Exhibit 106: Mitsubishi Chemical Holdings Corp. - Business segments
  • Exhibit 107: Mitsubishi Chemical Holdings Corp. - Key offerings
  • Exhibit 108: Mitsubishi Chemical Holdings Corp. - Segment focus
  • 10.8 Novartis AG
  • Exhibit 109: Novartis AG - Overview
  • Exhibit 110: Novartis AG - Business segments
  • Exhibit 111: Novartis AG - Key offerings
  • Exhibit 112: Novartis AG - Segment focus
  • 10.9 Pfizer Inc.
  • Exhibit 113: Pfizer Inc. - Overview
  • Exhibit 114: Pfizer Inc. - Product / Service
  • Exhibit 115: Pfizer Inc. - Key news
  • Exhibit 116: Pfizer Inc. - Key offerings
  • 10.10 Takeda Pharmaceutical Co. Ltd.
  • Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • 10.11 Viatris Inc.
  • Exhibit 121: Viatris Inc. - Overview
  • Exhibit 122: Viatris Inc. - Business segments
  • Exhibit 123: Viatris Inc. - Key offerings
  • Exhibit 124: Viatris Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 125: Inclusions checklist
  • Exhibit 126: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 127: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 128: Research methodology
  • Exhibit 129: Validation techniques employed for market sizing
  • Exhibit 130: Information sources
  • 11.5 List of abbreviations
  • Exhibit 131: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Product - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Product - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Product
  • Exhibits27: Data Table on Comparison by Product
  • Exhibits28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Product ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on France - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: AbbVie Inc. - Overview
  • Exhibits90: AbbVie Inc. - Product / Service
  • Exhibits91: AbbVie Inc. - Key offerings
  • Exhibits92: Amgen Inc. - Overview
  • Exhibits93: Amgen Inc. - Product / Service
  • Exhibits94: Amgen Inc. - Key offerings
  • Exhibits95: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits96: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits97: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits98: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits99: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits100: Johnson and Johnson - Overview
  • Exhibits101: Johnson and Johnson - Business segments
  • Exhibits102: Johnson and Johnson - Key news
  • Exhibits103: Johnson and Johnson - Key offerings
  • Exhibits104: Johnson and Johnson - Segment focus
  • Exhibits105: Mitsubishi Chemical Holdings Corp. - Overview
  • Exhibits106: Mitsubishi Chemical Holdings Corp. - Business segments
  • Exhibits107: Mitsubishi Chemical Holdings Corp. - Key offerings
  • Exhibits108: Mitsubishi Chemical Holdings Corp. - Segment focus
  • Exhibits109: Novartis AG - Overview
  • Exhibits110: Novartis AG - Business segments
  • Exhibits111: Novartis AG - Key offerings
  • Exhibits112: Novartis AG - Segment focus
  • Exhibits113: Pfizer Inc. - Overview
  • Exhibits114: Pfizer Inc. - Product / Service
  • Exhibits115: Pfizer Inc. - Key news
  • Exhibits116: Pfizer Inc. - Key offerings
  • Exhibits117: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits118: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits119: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits121: Viatris Inc. - Overview
  • Exhibits122: Viatris Inc. - Business segments
  • Exhibits123: Viatris Inc. - Key offerings
  • Exhibits124: Viatris Inc. - Segment focus
  • Exhibits125: Inclusions checklist
  • Exhibits126: Exclusions checklist
  • Exhibits127: Currency conversion rates for US$
  • Exhibits128: Research methodology
  • Exhibits129: Validation techniques employed for market sizing
  • Exhibits130: Information sources
  • Exhibits131: List of abbreviations